Recap: Entrada Therapeutics Q4 Earnings

Entrada Therapeutics TRDA reported its Q4 earnings results on Wednesday, March 13, 2024 at 07:00 AM.

Here's what investors need to know about the announcement.

Earnings

Entrada Therapeutics missed estimated earnings by -71.0%, reporting an EPS of $-0.29 versus an estimate of $-0.17.

Revenue was up $41.85 million from the same period last year.

Past Earnings Performance

Last quarter the company beat on EPS by $1.76 which was followed by a 1.0% drop in the share price the next day.

** Listen to the earnings announcement yourself by clicking here. **

To track all earnings releases for Entrada Therapeutics visit their earnings calendar here.

This article was generated by Benzinga's automated content engine and reviewed by an editor.